Literature DB >> 2219648

Efficacy of a baiting system for vaccinating foxes against rabies with vaccinia-rabies recombinant virus.

B M Brochier1, B Languet, M Artois, S Zanker, C Guittre, J Blancou, G Chappuis, P Desmettre, P P Pastoret.   

Abstract

The efficacy of a vaccinia-rabies recombinant virus (10(8) TCID50) contained in a machine-made baiting system has been tested in 22 captive young foxes which were divided into three experimental groups of six and a control group of four foxes. Each fox in groups 1, 2 and 3 were fed one, two and three vaccine-baits, respectively, on successive days. The four unvaccinated foxes were housed separately. As shown by the incorporation of a tetracycline biomarker into their bones, all the baited foxes ingested at least one bait. Thirty days after baiting seroconversion to rabies was observed in 15 (83 per cent) of the foxes and seroconversion to vaccinia in 14 (78 per cent). Sixteen of the 18 (89 per cent) baited foxes resisted a rabies challenge 30 days after baiting. One cub was protected against rabies despite the absence of detectable anti-rabies antibody. The results demonstrate that the bait-sachet system permits a good release of the virus suspension into the mouth.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2219648

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  5 in total

1.  The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and Pasteur.

Authors:  P P Pastoret; B Brochier
Journal:  Epidemiol Infect       Date:  1996-06       Impact factor: 2.451

2.  Raccoon dog rabies surveillance and post-vaccination monitoring in Lithuania 2006 to 2010.

Authors:  Dainius Zienius; Gediminas Pridotkas; Raimundas Lelesius; Vilimas Sereika
Journal:  Acta Vet Scand       Date:  2011-11-15       Impact factor: 1.695

Review 3.  Oral vaccination of wildlife using a vaccinia-rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG®): a global review.

Authors:  Joanne Maki; Anne-Laure Guiot; Michel Aubert; Bernard Brochier; Florence Cliquet; Cathleen A Hanlon; Roni King; Ernest H Oertli; Charles E Rupprecht; Caroline Schumacher; Dennis Slate; Boris Yakobson; Anne Wohlers; Emily W Lankau
Journal:  Vet Res       Date:  2017-09-22       Impact factor: 3.683

4.  Long-Term Immunogenicity and Efficacy of the Oral Rabies Virus Vaccine Strain SPBN GASGAS in Foxes.

Authors:  Conrad M Freuling; Verena Te Kamp; Antonia Klein; Maria Günther; Luca Zaeck; Madlin Potratz; Elisa Eggerbauer; Katharina Bobe; Christian Kaiser; Antje Kretzschmar; Steffen Ortmann; Peter Schuster; Adriaan Vos; Stefan Finke; Thomas Müller
Journal:  Viruses       Date:  2019-08-27       Impact factor: 5.048

5.  Comparable Long-Term Rabies Immunity in Foxes after IntraMuscular and Oral Application Using a Third-Generation Oral Rabies Virus Vaccine.

Authors:  Verena Te Kamp; Virginia Friedrichs; Conrad M Freuling; Ad Vos; Madlin Potratz; Antonia Klein; Luca M Zaeck; Elisa Eggerbauer; Peter Schuster; Christian Kaiser; Steffen Ortmann; Antje Kretzschmar; Katharina Bobe; Michael R Knittler; Anca Dorhoi; Stefan Finke; Thomas Müller
Journal:  Vaccines (Basel)       Date:  2021-01-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.